In our previous study [5,18], we assessed the effect of local IGFBP-4 gene therapy on a previously established subcutaneous cancer model and found that the IGFBP-4 and IGF-1R were overexpressed by the tumours. The gene discussed is IGFBP4; the disease is neoplasm.